Assenagon Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,986
| Closed | -$646K | – | 1415 |
|
|
2024
Q2 | $646K | Sell |
29,986
-50,740
| -63% | -$1.09M | ﹤0.01% | 1168 |
|
|
2024
Q1 | $2.17M | Sell |
80,726
-621,899
| -89% | -$16.8M | 0.01% | 843 |
|
|
2023
Q4 | $21.1M | Sell |
702,625
-174,515
| -20% | -$5.23M | 0.06% | 256 |
|
|
2023
Q3 | $18M | Buy |
877,140
+449,569
| +105% | +$9.21M | 0.06% | 248 |
|
|
2023
Q2 | $8.5M | Sell |
427,571
-5,017
| -1% | -$99.7K | 0.03% | 363 |
|
|
2023
Q1 | $7.41M | Sell |
432,588
-572,734
| -57% | -$9.81M | 0.03% | 440 |
|
|
2022
Q4 | $19.7M | Sell |
1,005,322
-379,612
| -27% | -$7.43M | 0.07% | 221 |
|
|
2022
Q3 | $22.1M | Sell |
1,384,934
-308,828
| -18% | -$4.93M | 0.08% | 213 |
|
|
2022
Q2 | $23.3M | Buy |
1,693,762
+373,201
| +28% | +$5.14M | 0.09% | 183 |
|
|
2022
Q1 | $20.9M | Buy |
1,320,561
+783,621
| +146% | +$12.4M | 0.06% | 216 |
|
|
2021
Q4 | $11.7M | Buy |
536,940
+507,588
| +1,729% | +$11.1M | 0.03% | 268 |
|
|
2021
Q3 | $877K | Sell |
29,352
-6,359
| -18% | -$190K | ﹤0.01% | 898 |
|
|
2021
Q2 | $1.58M | Sell |
35,711
-161
| -0.4% | -$7.13K | 0.01% | 733 |
|
|
2021
Q1 | $1.59M | Sell |
35,872
-8,428
| -19% | -$374K | 0.01% | 738 |
|
|
2020
Q4 | $2.43M | Sell |
44,300
-300,429
| -87% | -$16.5M | 0.01% | 450 |
|
|
2020
Q3 | $7.88M | Sell |
344,729
-147,637
| -30% | -$3.38M | 0.04% | 212 |
|
|
2020
Q2 | $10.3M | Buy |
+492,366
| New | +$10.3M | 0.07% | 165 |
|
|
2019
Q3 | – | Sell |
-230,342
| Closed | -$3.46M | – | 995 |
|
|
2019
Q2 | $3.46M | Buy |
230,342
+170,775
| +287% | +$2.56M | 0.03% | 340 |
|
|
2019
Q1 | $1.05M | Buy |
59,567
+14,961
| +34% | +$262K | 0.01% | 637 |
|
|
2018
Q4 | $661K | Buy |
+44,606
| New | +$661K | 0.01% | 717 |
|